» Articles » PMID: 34045808

Clinical Predictive Values in Botulism: A 10-year Survey

Overview
Specialty Critical Care
Date 2021 May 28
PMID 34045808
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Botulism occurs periodically or in outbreaks in Iran. Botulism is lethal and accordingly a considerable issue in environmental health, although it is uncommon. This study was performed to evaluate the potential predictive factors in foodborne botulism in a 10-year span.

Materials And Methods: All medical records from patients with foodborne botulism admitted to Imam Reza Hospital in 10 years (2005-2015) were analyzed retrospectively.

Results: 61 cases were included (38 men, mean age ± SD 28.93 ± 19.14 years). All cases were treated with antitoxin. 6.6% of cases died. Canned beans were correlated with the admission to intensive care unit (ICU), and also, it increased the length of ICU stay significantly ( = 0.007 and 0.023, respectively). The incidence of dizziness and diplopia significantly induced excess demands for higher doses of antitoxin ( = 0.038 and 0.023, respectively). Risk of dysphagia was remarkably higher in cases with ptosis ( = 0.039, odds ratio: 3). While in this study, time elapsed between the onset of clinical manifestations and antitoxin administration was correlated with the occurrence of dysphagia, constipation, and blurred vision, and early treatment did not improve the outcomes. Multiple analysis of potential variables by a logistic regression model disclosed that the independent significant factors affecting mortality were the need for mechanical ventilation ( = 0.000), dyspnea ( = 0.044), general weakness ( = 0.044), and lack of consciousness ( = 0.008) at the time of admission.

Conclusions: Taking clinical signs and symptoms into account upon patient arrival is important and, of course, is a key to further management in the emergency setting.

How To Cite This Article: Saeidi S, Dadpour B, Jarahi L, Ghamsari AA, Nooghabi MN. Clinical Predictive Values in Botulism: A 10-year Survey. Indian J Crit Care Med 2021;25(4):411-415.

Citing Articles

Production of monoclonal antibodies against botulinum neurotoxin in .

Sangprasat K, Bulaon C, Rattanapisit K, Srisangsung T, Jirarojwattana P, Wongwatanasin A Hum Vaccin Immunother. 2024; 20(1):2329446.

PMID: 38525945 PMC: 10965107. DOI: 10.1080/21645515.2024.2329446.


Foodborne botulism: A brief review of cases transmitted by cheese products (Review).

Chaidoutis E, Keramydas D, Papalexis P, Migdanis A, Migdanis I, Lazaris A Biomed Rep. 2022; 16(5):41.

PMID: 35386113 PMC: 8972315. DOI: 10.3892/br.2022.1524.

References
1.
Hatheway C, SNYDER J, Seals J, Edell T, Lewis Jr G . Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis. 1984; 150(3):407-12. DOI: 10.1093/infdis/150.3.407. View

2.
Arnon S, Schechter R, Maslanka S, Jewell N, Hatheway C . Human botulism immune globulin for the treatment of infant botulism. N Engl J Med. 2006; 354(5):462-71. DOI: 10.1056/NEJMoa051926. View

3.
Kongsaengdao S, Samintarapanya K, Rusmeechan S, Wongsa A, Pothirat C, Permpikul C . An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis. 2006; 43(10):1247-56. DOI: 10.1086/508176. View

4.
Cowden J . Food-borne Clostridium botulinum intoxication from mass produced foodstuffs in Europe. Euro Surveill. 2011; 16(49):20033. DOI: 10.2807/ese.16.49.20033-en. View

5.
Wongtanate M, Sucharitchan N, Tantisiriwit K, Oranrigsupak P, Chuesuwan A, Toykeaw S . Signs and symptoms predictive of respiratory failure in patients with foodborne botulism in Thailand. Am J Trop Med Hyg. 2007; 77(2):386-9. View